Icon Group named a finalist in esteemed AFR Aspire Awards
Icon Group has been named a finalist in the 2016 Aspire Awards presented by Financial Review and PwC's Private Clients' division.
The awards recognise the best of Australia’s private and family businesses, highlighting outstanding organisations that shape our economy and society.
Icon Group has been named a finalist in the highly competitive Private Business Growth and Transformation category, which recognises businesses that have successfully:
- Transformed themselves in order to grow
- Adapted to changing environment/demands
- Had sustainable growth over time
Mark Middleton, Icon Group CEO, said “This announcement is another confirmation of our commitment to patients, and the positive impact we are having on the healthcare industry and society. Over the last two years we have evolved from a day oncology hospital to deliver a full profile of cancer care services including medical oncology, haematology, radiation oncology, pharmacy and chemotherapy compounding. The result is an integrated cancer care model that is committed to supporting patients through every step of their treatment.”
Winners will be announced at an awards presentation in Sydney on 9 November 2016.
About Icon Group
Icon Group is Australia’s largest dedicated cancer care provider and has expanded globally into Singapore, Mainland China, Hong Kong and New Zealand.
People from across Icon Group share their stories of success, career progression and being iconic.
A career with Icon
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Read the latest news and updates across Icon Group.